These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6206017)

  • 21. Age, weight and circulating concentrations of total testosterone are associated with the relative prostatic size in adult intact male dogs.
    Holst BS; Nilsson S
    Theriogenology; 2023 Mar; 198():356-360. PubMed ID: 36640740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
    Bartsch W; Becker H; Pinkenburg FA; Krieg M
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in serum sex hormone-binding globulin and in serum non-sex hormone-binding globulin-bound testosterone during prepuberty in boys.
    Belgorosky A; Rivarola MA
    J Steroid Biochem; 1987; 27(1-3):291-5. PubMed ID: 3695486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous infusion of low dose growth hormone decreases serum sex-hormone binding globulin and testosterone concentrations in moderately obese middle-aged men.
    Oscarsson J; Lindstedt G; Lundberg PA; Edén S
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):23-9. PubMed ID: 8706289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
    Carter HB; Pearson JD; Metter EJ; Chan DW; Andres R; Fozard JL; Rosner W; Walsh PC
    Prostate; 1995 Jul; 27(1):25-31. PubMed ID: 7541528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men.
    Erfurth EM; Hagmar LE; Sääf M; Hall K
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):659-64. PubMed ID: 8801037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma sex hormone binding globulin in patients with prostatic carcinoma.
    Grasso M; Buonaguidi A; Mondina R; Borsellino G; Lania C; Banfi G; Rigatti P
    Cancer; 1990 Jul; 66(2):354-7. PubMed ID: 1695120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study.
    Chubb SA; Hyde Z; Almeida OP; Flicker L; Norman PE; Jamrozik K; Hankey GJ; Yeap BB
    Eur J Endocrinol; 2008 Jun; 158(6):785-92. PubMed ID: 18505902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG.
    Giton F; Urien S; Born C; Tichet J; Guéchot J; Callebert J; Bronsard F; Raynaud JP; Fiet J
    Clin Chem; 2007 Dec; 53(12):2160-8. PubMed ID: 17932133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.
    Zhang J; Huang X; Liao M; Gao Y; Tan A; Yang X; Zhang H; Mo L; Zhang Y; Lu Z; Wu C; Hu Y; Mo Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):391-7. PubMed ID: 23463406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P
    Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
    Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
    Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.
    Leinonen P; Hammond GL; Lukkarinen O; Vihko R
    Invest Urol; 1979 Jul; 17(1):24-7. PubMed ID: 571863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model.
    Cooke RR; McIntosh JE; McIntosh RP
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):163-71. PubMed ID: 8370129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced circulating androgen bioactivity in patients with prostate cancer.
    Raivio T; Santti H; Schatzl G; Gsur A; Haidinger G; Palvimo JJ; Jänne OA; Madersbacher S
    Prostate; 2003 May; 55(3):194-8. PubMed ID: 12692785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes.
    Hu J; Zhang A; Yang S; Wang Y; Goswami R; Zhou H; Zhang Y; Wang Z; Li R; Cheng Q; Zhen Q; Li Q
    J Diabetes; 2016 Jul; 8(4):508-15. PubMed ID: 26119029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.